Printer Friendly

Penumbra Inc reports operating loss of USD0.9m for 2018.

M2 EQUITYBITES-February 27, 2019-Penumbra Inc reports operating loss of USD0.9m for 2018

(C)2019 M2 COMMUNICATIONS http://www.m2.com

Healthcare company Penumbra Inc (NYSE:PEN) stated on Tuesday that it recorded an operating loss of USD0.9m for the year ended 31 December 2018.

This marks a decline in earnings when compared with operating income of USD1.2m for the year ended 31 December 2017.

Total revenue of USD444.9m was collected for the year ended 31 December 2018, a rise of 33.3%, or 32.2% in constant currency over total revenue of USD333.8m for 2017, The US represented 65% of total revenue and international represented 35% of total revenue for the year ended 31 December 2018.

R&D expenses of USD36.2m were recorded for the year ended 31 December 2018, an increase versus R&D of USD31.7m for the year ended 31 December 2017.

For 2019, the company expects total revenue to be in the range of USD525m to USD535m.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Article Type:Financial report
Date:Feb 27, 2019
Words:178
Previous Article:Spotify announces launch of services in India.
Next Article:Fluence announces commercial agreement worth EUR165m with Ivory Coast government.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters